FDA-Approved Essilor Stellest Lenses Designed to Mitigate Myopia Progression
-
By
-
Matthew Perrone
-
December 1, 2025
By
Matthew Perrone
December 1, 2025
by Matthew Perrone
December 1, 2025
Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia
May 8, 2026
Repeated low-level-red-light therapy – a powerful new approach to myopia management
by Julian Upton
November 25, 2023